GRACE :: Global Resource for Advancing Cancer Education
  • Recent GRACE News & Posts

    • Survey for Lung Cancer Chemo Patients Seeks to Improve Care [GRACE :: Lung Cancer]
      Cancer researchers need to hear from lung cancer patients who have gone through chemotherapy and experienced various side effects. As part of that effort, GRACE is supporting the Research Advocacy Network, a non-profit organization, as it searches for lung cancer
    • FAQ: What is Neoadjuvant Therapy and Why Would We Want to Give it? [GRACE :: Cancer Basics]
      The cornerstone of treatment of an earlier stage cancer is a local therapy such as surgery or radiation, which is meant to remove or destroy the cancer that is limited to a specific area. We know, however, that people who have undergone complete resection or what s
    • Lung Cancer Leaps Expected at Scientific Meeting [GRACE :: Lung Cancer]
      Dr. Thomas John is a thoracic oncologist at the Olivia Newton-John Cancer and Wellness Centre in Australia. The American Society of Clinical Oncology's (ASCO) Annual Meeting brings together 30,000 oncology professionals from around the world. Educational sessions
    • This Is Not a Request for Donations... [GRACE :: News/Info]
      GRACE helps patients and their families figure things out during incredibly challenging times.   We know what you are going through, as much as any other person not living in your shoes can.  We are with you. So it makes us a little squeamish to ask you for a don
    • PFS vs. pfs: Why Progression-Free Survival Remains Controversial in Lung Cancer [GRACE :: Lung Cancer]
      Last year, an article came out in the Journal of Clinical Oncology that noted a gradual shift away from the "hard endpoint" of overall survival (OS) for lung cancer trials toward progression-free survival (PFS), a "softer endpoint" that is much more subject to inte
    • Questions & Answers with Drs. Pal, Luke and Wolchok about Immunotherapy for Cancer [GRACE :: Treatments & Symptom Management]
      Immunotherapy Forum Video #31: "You know the world is changing when you have to change the rules..." Following presentations on endpoints and biomarkers in cancer immunotherapy, the doctors take questions from the audience. [powerpress]
    • The Immunotherapy Cola Wars [GRACE :: Lung Cancer]
      It's been a big week for immunotherapy for lung cancer. Right on the heels of a press release that the PD-1 inhibitor Opdivo (nivolumab) significantly improved survival for patients with advanced non-squamous NSCLC, my friend Dr. Garon from UCLA presented results a
    • Immunotherapy Opdivo (Nivolumab) Non-Squamous NSCLC Trial Stopped, Reported as Positive [GRACE :: Lung Cancer]
      In January, 2015, the CheckMate 017 trial of the immune checkpoint inhibitor Opdivo (nivolumab) versus the standard chemo agent Taxotere (docetaxel) as second line therapy for patients with advanced squamous NSCLC was reported in a press release to be positive for
    • Redefining Success and Failure in Cancer Immunotherapy Trials [GRACE :: Treatments & Symptom Management]
      Immunotherapy Forum Video #30: Immunotherapy for cancer has rewritten the rules for what we consider a successful response to treatment. Some tumors grow before they regress. Dr. Jedd Wolchok discusses why a new measurement criteria was developed. [powerpress]
    • The Future of Cancer Immunotherapy: Combination Treatments [GRACE :: Treatments & Symptom Management]
      Immunotherapy Forum Video #29: In part 2 of 2, Dr. Jason Luke discusses treating cancer with immunotherapy and another drug, such chemotherapy or targeted therapies, as well as what we know about biomarkers that predict if an immunotherapeutic will work. [powerpre
    • The Right Time for Cancer Immunotherapy: Before or After Surgery? [GRACE :: Treatments & Symptom Management]
      Immunotherapy Forum Video #28: Doctors are still weighing the pros and cons of giving a cancer patient immunotherapy before or after resection surgery. In part 1 of 2 videos, Dr. Jason Luke details those risks and benefits. [powerpress]
    • Who Benefits from Immunotherapy? [GRACE :: Treatments & Symptom Management]
      Immunotherapy Forum Video #27: Immunotherapies work well in some, but not in others. Who benefits, and why? Dr. Sumanta (Monty) Pal explains what doctors are learning. [powerpress]

Ask Us, Q&A

Volunteers Needed
We're Exhibiting At ASCO

 

Immunotherapy Patient Forum 2014 Videos

 


GRACE Website Rebuild

Acquired Resistance Forum Videos

 

ALK+ Lung Cancer Patient Forum Videos

Join the GRACE Faculty

Lung/Thoracic Cancer Blog
Breast Cancer Blog
Pancreatic Cancer Blog
Kidney Cancer Blog
Bladder Cancer Blog
Head/Neck Cancer Blog

Subscribe to the GRACEcast Podcast on iTunes

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon

Subscribe to
GRACE Notes
   (Free Newsletter)

Other Resources

ClinicalTrials.gov


Biomedical Learning Institute

peerview_institute_logo_243